Adults with relapsing multiple sclerosis: Ponesimod reduces the annual rate of relapse
Results from the phase 3 OPTIMUM study, which evaluated the efficacy and safety of Ponesimod compared to Teriflunomide ( Aubagio ) in adults with relapsing multiple sclerosis were announced.
The stud ...
read article